“Just because a new medication works on cancer cells in a petri dish or mice doesn’t mean it will work in children or is safe in children. It is crucial to carefully and responsibly test new therapies…at present, we over 30 open clinical trials for children with brain tumors. However, it is crucial to expand our clinical research program so that we can support the development and testing of new cutting edge therapies as well as expand the treatment options available for our patients today.”
– Dr. Michael J. Fisher, Chief of the Section of Neuro-Oncology, Children’s Hospital of Philadelphia
The Children’s Hospital of Philadelphia’s Neuro-Oncology Department sees more patients than any other children’s hospital in the country. The increase in patients that come through their unit has caused a need for growth in their program for clinician/researchers to adequately care for the patients as well as work on research to find better treatments and cure. The Kortney Rose Foundation is proud to be investing in this growth over the next couple of years.